Association Between Cabozantinib and Skin Reactions in Urothelial Carcinoma
The relationship and frequency skin reactions in urothelial carcinoma who are being treated only cabozantinib evaluated.
The relationship and frequency skin reactions in urothelial carcinoma who are being treated only cabozantinib evaluated.
Active smokers more knowledgeable of bladder cancer risk than former, never smokers; often cite urologist as source of info.
Cripto-1 gene overexpression may play role in the development of bladder cancer.
Patients with bladder cancer who did not receive an optimal biopsy were more likely to die from their disease.
Researchers have identified genetic alterations that contribute to the development of bladder cancer.
1 in 10 patients with cancer would be more accurately diagnosed if their tumors were defined by cellular and molecular criteria.
Matt Zibelman, MD, discusses research in genitourinary cancer that was presented at the 2014 American Society of Clinical Oncology Annual Meeting.
New predictors of tumor recurrence are necessary for patients with non-muscle invasive bladder cancer, according to a study published in PLOS One.
Physical activity is associated with a reduction in bladder cancer-specific mortality and female Medicare beneficiaries are less likely to receive a complete hematuria evaluation.
The use of neoadjuvant and adjuvant chemotherapy for the treatment of muscle-invasive bladder cancer is associated with a survival benefit in the general population, and may be underutilized.